The inaugural ATNF conference, held from 15–17 April 2025, brought together stakeholders across the...
Navigating the Future of Reduced-Risk Nicotine Products: Insights from NGND Miami 2025
The Next Generation Nicotine Delivery (NGND) conference in Miami delivered an energetic and insightful dialogue on the future of reduced-risk products in the U.S. and beyond. With the FDA’s direction high on the agenda, discussions were robust, and...
Results - 93 Blogs
As global economic dynamics shift, the reduced-risk nicotine industry, already contending with...
EVO NXT 2025 in Milan offered a refreshing departure from traditional large-scale expos. The event...
The UK heated tobacco market continues to evolve rapidly, with growing consumer interest and an...
Understanding the UAE’s Final Draft Regulation for Nicotine Pouches: What It Means for Manufacturers
The Ministry of Industry and Advanced Technology (MoIAT) has recently issued the Final Draft...
The nicotine pouch market in the US is growing rapidly, but so is regulatory scrutiny. The FDA’s...
The U.S. Food and Drug Administration (FDA) has set out a rigorous regulatory framework for...
Examining the legal frameworks for new analogues
On January 16, 2025, the FDA granted marketing authorisation for Swedish Match’s Zyn nicotine...
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
